Ouzouni Apostolina, Plataniotis Georgios A, Capizzello Antonio, Gkantaifi Areti, Tsaloglidou Areti, Galanos Antonios, Lavdaniti Maria
Department of Clinical Pathology, American Hellenic Educational and Progressive Association (AHEPA) Hospital, Aristoteles of Thessaloniki, Thessaloniki, GRC.
Department of Radiation Oncology, American Hellenic Educational and Progressive Association (AHEPA) Hospital, Aristoteles of Thessaloniki, Thessaloniki, GRC.
Cureus. 2025 Jul 22;17(7):e88540. doi: 10.7759/cureus.88540. eCollection 2025 Jul.
Radiotherapy constitutes a fundamental modality in breast cancer treatment; however, it is often accompanied by considerable patient fear, psychological distress, and unmet informational needs. Addressing these factors may enhance patient compliance and quality of care.
A longitudinal cohort study was conducted at two radiotherapy departments in Thessaloniki, Greece, from October 2022 to May 2023. A total of 216 breast cancer patients were enrolled and assigned to a control group (n = 98), receiving standard care, or an intervention group (n = 118), receiving an informational brochure detailing radiotherapy procedures. Validated Greek versions of the Questionnaire for Assessing Fear of Radiotherapy in Oncology Patients (QAFRT), the M.D. Anderson Symptom Inventory (MDASI), the Information Styles Questionnaire (ISQ), and the Profile of Mood States Short Form (POMS-S) were administered at baseline and upon completion of radiotherapy.
At baseline, groups were homogeneous in demographics and clinical characteristics, except for education level (P < 0.0005). Significant reductions in fear scores were observed in the intervention group across all QAFRT subscales (P < 0.0005), including fear of treatment effectiveness, illness during therapy, daily life disruption, and side effects. The intervention group also demonstrated significant improvements in psychological well-being, with reductions in tension, depression, anger, fatigue, and confusion, and increased vigor on the POMS-S (P < 0.0005). Symptom burden, as assessed by MDASI, improved significantly across all domains in the intervention group (P < 0.0005). Furthermore, informational needs regarding disease and treatment were significantly reduced in the intervention group post-intervention (P = 0.001), while psychological informational needs remained unchanged.
Providing structured, written informational support prior to radiotherapy initiation significantly reduces fear, improves mood states, and alleviates symptom burden in breast cancer patients. These findings highlight the importance of tailored patient education in optimizing radiotherapy experiences and psychological outcomes.
放射治疗是乳腺癌治疗的一种基本方式;然而,它常常伴随着患者相当程度的恐惧、心理困扰以及未得到满足的信息需求。解决这些因素可能会提高患者的依从性和护理质量。
2022年10月至2023年5月在希腊塞萨洛尼基的两个放射治疗科室进行了一项纵向队列研究。总共招募了216名乳腺癌患者,并将其分为对照组(n = 98),接受标准护理,以及干预组(n = 118),接受一份详细介绍放射治疗程序的信息手册。在基线时以及放疗结束时,使用经过验证的希腊语版肿瘤患者放疗恐惧评估问卷(QAFRT)、MD安德森症状量表(MDASI)、信息风格问卷(ISQ)以及情绪状态简表(POMS - S)进行评估。
在基线时,除教育水平外(P < 0.0005),两组在人口统计学和临床特征方面具有同质性。在干预组中,所有QAFRT子量表的恐惧得分均显著降低(P < 0.0005),包括对治疗效果的恐惧、治疗期间患病、日常生活干扰以及副作用。干预组在心理健康方面也有显著改善,POMS - S量表上的紧张、抑郁、愤怒、疲劳和困惑程度降低,活力增加(P < 0.0005)。通过MDASI评估的症状负担在干预组的所有领域均有显著改善(P < 0.0005)。此外,干预组在干预后关于疾病和治疗的信息需求显著减少(P = 0.001),而心理信息需求保持不变。
在放疗开始前提供结构化的书面信息支持可显著降低乳腺癌患者的恐惧、改善情绪状态并减轻症状负担。这些发现凸显了量身定制患者教育对于优化放疗体验和心理结果的重要性。